Skyscape Web Viewer : Skyscape Rx™ - Drug Guide : Use and Dosing

View All
Pathological hypersecretory conditions - omeprazole(adult)
Pathological hypersecretory conditions- ranitidine [Oral](adult)
Patient <=20 kg- acetylcysteine [IV](peds)
Patient >=20 kg - <40 kg- acetylcysteine [IV](adult)
Patient >=20 kg-<40 kg- acetylcysteine [IV](peds)
Patient >=40 kg- acetylcysteine [IV](adult)
Patient >=40 kg- acetylcysteine [IV](peds)
Patients >16 yrs- pentamidine [Inhaled](peds)
Patients currently taking methylphenidate- dexmethylphenidate(adult)
Patients currently taking methylphenidate- dexmethylphenidate(peds)
Patients harbouring extremely sensitive organisms- flucytosine [IV](adult)
Patients harbouring extremely sensitive organisms- flucytosine [IV](peds)
Patients not receiving diuretics- moexipril(adult)
Patients not taking methylphenidate- dexmethylphenidate(adult)
Patients not taking methylphenidate- dexmethylphenidate(peds)
Patients not treated with an ESA (Erythropoiesis-Stimulating Agent)- peginesatide [IV/SC](adult)
Patients not treated with an ESA (Erythropoiesis-Stimulating Agents)- methoxy polyethylene glycol-epoetin beta [IV/SC](adult)
Patients on metformin- metformin/saxagliptin(adult)
Patients receiving argatroban at doses greater than 2 mcg/kg/min- argatroban [IV](adult)
Patients receiving argatroban up to 2 mcg/kg/min- argatroban [IV](adult)
Patients receiving carbidopa-levodopa product who require additional carbidopa- carbidopa(adult)
Patients receiving diuretics- moexipril(adult)
Patients requiring individual titration of carbidopa and levodopa- carbidopa(adult)
Patients requiring saxagliptin 2.5 mg in combination with metformin extended-release- metformin/saxagliptin(adult)
Patients requiring saxagliptin 5 mg and who are currently not treated with metformin- metformin/saxagliptin(adult)
Patients treated with an ESA- methoxy polyethylene glycol-epoetin beta [IV/SC](adult)
Patients with confirmed osteoblastic metastatic bone lesions- samarium Sm-153 lexidronam [IV](adult)
Patients with confirmed osteoblastic metastatic bone lesions- samarium Sm-153 lexidronam [IV](peds)
Patients with heterozygous Familial Hypercholesterolemia (10-17 yrs)- simvastatin(peds)
Patients with Homozygous Familial Hypercholesterolemia- simvastatin(adult)